Giles Ai Ltd secures £370k for medical research AI platform

Researchers and product teams in the healthcare and life-science sectors use a generative, medical-grade AI assistant developed by the London-based firm, which has just raised the estimated sum. The platform extracts structured insights from millions of scientific articles to accelerate research through real-time recommendations and workflow optimisation.

The business operates within the business and domestic software development sector and was incorporated in 2023. This latest funding round brings the total capital raised by the company during 2026 to £570k.

This year's investment activity follows a 2025 period in which the business secured a total of £690.6k in funding. The most recent accounts for the firm cover the financial year ending 31 August 2025. Documentation for this latest allotment was filed in September 2026 (following a share issuance earlier that month).